U.S. lawmakers allocate $9.4 billion for global health in 2026. Plus, U.S. CDC staff are worried about the agency's future, and the WHO chief has a new year's wish for the agency.
Opinion: Nepal records some of South Asia's highest snakebite mortality rates, yet relies almost entirely on imported antivenom that often runs out during monsoon season when risk peaks. The recurring deaths aren’t a medical mystery — they’re a policy failure.
Opinion: Kenya’s $2.5 billion health deal with the U.S. isn’t unique — at least 13 countries have made similar deals, trading health data for funding. When citizens lose control of their data, they lose its benefits and their agency.
The U.S. CDC's global health work hangs in the balance. Plus, what 2026 has in store for food systems.
Opinion: Existing global efforts to tackle menstrual discrimination have predominantly focused on menstrual hygiene, rather than taking a holistic approach that integrates menstrual health and dignity into broader social, economic, human rights and health dialogues.
Key leadership changes are set for several global health organizations in 2026. Plus, the UNAIDS board is rolling out a new transition process, and questions are rising over the conditions attached to new U.S. health deals.
Opinion: How do we protect access to health care when countries are losing the fiscal space to do it?